COVID-19 In Cardio Oncology

COVID-19 in Cardio-Oncology Guest: Joerg Herrmann, M.D. (@mayocvonc) Host: Malcolm R. Bell, M.D. Coronavirus disease 2019 (COVID-19), heart disease and cancerous tumors were the top three causes of death in the U.S. in 2020. Providers recognized early in the COVID-19 pandemic that patients with underlying cardiovascular disease or cardiovascular risk factors were at the highest risk of developing a severe course and even dying of COVID-19. Patients with cancer also had a higher risk of severe and fatal outcomes. Joining us today to discuss COVID-19, heart disease and oncology treatment of tumors is Joerg Herrmann, M.D., director of the Cardio-Oncology Clinic at Mayo Clinic in Rochester, Minnesota. Specific topics discussed: Relationship between heart disease, cancerous tumors and COVID-19 Research in the connection between cardiac disease and an underlying tumor or the result of treatment of a tumor Changes to patient care during the pandemic Remote monitoring of patients and innovative artificial intelligence applications Cardio-oncology lessons learned Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV. No CME credit offered for this episode. Podcast episode transcript found here.